PharmaVoice

JANUARY 2, 2025

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

321

321

Drug Topics

JANUARY 2, 2025

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses the benefits of glucagon and why pharmacists should be able to prescribe it.

247

247

Pharmacy Times

JANUARY 2, 2025

Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.

145

145

Drug Topics

JANUARY 2, 2025

Jennifer Goldman, PharmD, CDCES, BC-ADM, discusses how putting glucagon kits in public areas and long-term care facilities can help patients with diabetes.

Long-Term Care Facilities 247

Long-Term Care Facilities 247

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Healthcare

JANUARY 2, 2025

In this month's payer roundup, CVS faces antitrust questions from Congress as the company lays off more workers following a failed Medicaid bid in Kansas, Oscar Health CEO Mark Bertolini has a bold idea to remake health insurance and Johnson & Johnson is suing Express Scripts in a long-running lawsuit.

Insurance 142

Insurance 142

Drug Topics

JANUARY 2, 2025

XG005 from Xgene Pharmaceutical is a novel, non-opioid chemical entity that targets anti-nociceptive and anti-neuropathic pain pathways.

190

190

Fierce Healthcare

JANUARY 2, 2025

The group is concerned about understaffing, retention challenges and low pay. NYC H+H affiliates and the Doctors Council have been negotiating a new contract for 15 months.

124

124

Pharmacy Times

JANUARY 2, 2025

Treatment options may include treating the anemia with blood transfusions, androgen therapy, thalidomide, and other medications.

123

123

pharmaphorum

JANUARY 2, 2025

The challenges facing oncology clinical trials are multifaceted, but there is a clear opportunity for pharmaceutical companies to rethink their approach to clinical research, and prioritise the patient from the beginning.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies 115

Pharmacy Times

JANUARY 2, 2025

The approval offers patients with solid tumors an alternative to intravenous PD-1 inhibitor administration.

FDA 123

FDA 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 2, 2025

Early cancer diagnoses have risen to record levels in England, says NHS, but long waiting times for treatment threaten to undermine the gains.

111

111

Pharmacy Times

JANUARY 2, 2025

Patients with relapsed, refractory disease achieved deep, durable responses with equecabtagene autoleucel.

122

122

Pharmaceutical Technology

JANUARY 2, 2025

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.

109

109

Pharmacy Times

JANUARY 2, 2025

Pharmacists can educate patients on controlling risk factors and stay up-to-date on emerging therapies like SGLT2 inhibitors and finerenone that can slow disease progression.

122

122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JANUARY 2, 2025

Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market

105

105

Fierce Healthcare

JANUARY 2, 2025

HHS is backing away from a proposed rule that would've worked around an employer's religious objections to contraceptive coverage without cost sharing.

105

105

pharmaphorum

JANUARY 2, 2025

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug

105

105

Pharmacy Times

JANUARY 2, 2025

Immunocompromised older adults developed fewer antibodies against RSV following vaccination compared with immunocompetent individuals.

Vaccines 93

Vaccines 93

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 2, 2025

The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price

104

104

The Checkup by Singlecare

JANUARY 2, 2025

Benadryl (with the active ingredient diphenhydramine Hcl) is an allergy medication and over-the-counter antihistamine. It works as an histamine receptor antagonist against histamine receptors, blocking histamine from binding and preventing allergic reactions. It can treat hay fever, allergy symptoms, cold symptoms, and insomnia. People can take it as a capsule, tablet, orally dissolving film, or liquid.

Adverse Reactions 91

Adverse Reactions Dosage Immunization 91

pharmaphorum

JANUARY 2, 2025

Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.

98

98

The Checkup by Singlecare

JANUARY 2, 2025

Glucagon-like peptide-1 receptor agonists (GLP-1s) are drugs that act like the GLP-1 hormone that the human body should release naturally in the gastrointestinal tract after eating. GLP-1 performs many functions in the body, including triggering the release of insulin from the pancreas, improving insulin resistance, slowing down the emptying of the stomach, and increasing the feeling of satiety.

Labelling 91

Labelling FDA 91

Pharmacy Times

JANUARY 2, 2025

PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models

73

73

Fierce Healthcare

JANUARY 2, 2025

UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal challenge to the deal. | UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal challenge to the deal.

71

71

Pharmacy Times

JANUARY 2, 2025

The regulatory decision marks a significant step forward in the treatment of non-tuberculous mycobacteria infections.

FDA 65

FDA 65

Fierce Healthcare

JANUARY 2, 2025

NeueHealth, the care management company formerly known as Bright Health, is set to be acquired by venture capital partner New Enterprise Associates later this month. | NeueHealth is getting bought out by an affiliate of New Enterprise Associates, making the company privately held.

68

68

Pharmacy Times

JANUARY 2, 2025

The model, Deep-IO, shows improved specificity and sensitivity compared with existing predictive biomarkers.

Immunization 65

Immunization 65

Pharmaceutical Technology

JANUARY 2, 2025

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.

64

64

Pharmacy Times

JANUARY 2, 2025

Although each of the product samples of phenibut contained the actual active ingredient, the exact amount of the active ingredient was inaccurate and, in one sample, found to be at a higher dose.

65

65

Pharmaceutical Technology

JANUARY 2, 2025

Explore how strategic intelligence agencies and competitive intelligence solutions are shaping the pharmaceutical industry. Download our guide to technological advancements and more invaluable industry insights.

59

59

Pharmacy Times

JANUARY 2, 2025

The big three PBMs rake in billions from government drug programs while patients pay more and small pharmacies are squeezed out, says NCPA

65

65

Pharmaceutical Technology

JANUARY 2, 2025

The Phase III KOASTAL-1 study with Neumoras lead asset navacaprant failed to meet its primary and secondary endpoint.

59

59

Pharmacy Times

JANUARY 2, 2025

Congress fumbled a chance to rein in big insurance and PBMs and save taxpayers billions, says NCPA

Insurance 65

Insurance 65